Reporter cell lines are useful tools for monitoring biological activity of nuclear receptor ligands

Luminescence

Volumn 16, Issue 2, 2001, Pages 153-158

  Balaguer, Patrick ^a   Boussioux, Anne Marie ^a   Demirpence, Ediz ^a   Nicolas, Jean Claude ^a  

^a INSERM   (France)

Author keywords

Chimaeric nuclear receptor; Firefly luciferase; Nuclear receptors ligands; Stable transfection; Subtype selective retinoids; Xeno oestrogens

Indexed keywords

CELL RECEPTOR; ESTROGEN; LIGAND; LUCIFERASE; RETINOID;

ARTICLE; CELL LINE; GENETICS; HUMAN; METABOLISM; REPORTER GENE; SIGNAL TRANSDUCTION;

CELL LINE; ESTROGENS; GENES, REPORTER; HUMANS; LIGANDS; LUCIFERASES; RECEPTOR CROSS-TALK; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOIDS;

CELL CULTURE; DNA; GENE EXPRESSION; LANTHANUM COMPOUNDS; LIGANDS; MOLECULAR BIOLOGY; PLANTS (BOTANY);

CHIMERIC NUCLEAR RECEPTOR; FIREFLY LUCIFERASE; NUCLEAR RECEPTOR LIGAND; NUCLEAR RECEPTORS; OESTROGENS; RECEPTOR LIGANDS; RETINOIDS; STABLE TRANSFECTION; SUBTYPE-SELECTIVE RETINOID; XENO-ESTROGEN;

BIOACTIVITY;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035289417     PISSN: 15227235     EISSN: None     Source Type: Journal    
DOI: 10.1002/bio.630     Document Type: Article

References (13)

1. Gronemeyer H, Moras D. Nuclear receptors. Protein Profile 1995; 2: 1173-1308.
2. Kuiper GJM, Lemmen JG, Carlsson B et al. Interaction with estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998; 139: 4252-4263.
3. Mangelsdorf DJ, Thummel C, Beato M et al. The nuclear receptor family: the second decade. Cell 1995; 83: 835-839.
4. Joyeux A, Balaguer P, Germain P, Pons M, Nicolas J-C. Engineered cell lines as a tool for monitoring biological activity of hormone analogs. Anal. Biochem. 1997; 249: 119-130.
5. Balaguer P, François F, Comunale F, Fenet H, Boussioux A-M, Pons M, Nicolas J-C, Casellas C. Reporter cell lines to study the estrogenic effects of xenoestrogens. Sci. Tot. Environ. 1999; 233: 47-56.
6. Green S, Issemann I, Sheer E. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 1988; 16: 369.
7. Demirpence E, Balaguer P, Trousse F, Pons M, Gagne D. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element but through different molecular mechanisms. Cancer Res. 1994; 54: 1458-1464.
8. Pratt MAC, Deonarine D, Teixera C, Novosad D, Tate BF, Grippo JF. The AF-2 region of the retinoic acid receptor α mediates retinoic acid inhibition of estrogen receptor function in breast cancer cells. J. Biol. Chem. 1996; 271: 20346-20352.
9. Kagechika H, Kawachi E, Hashimoto Y, Himi T, Shudo K. Structure-activity relations of aromatic amides. J. Med. Chem. 1988; 31: 2182-2192.
10. Martin B, Bernardon J, Cavey M et al. Selective synthetic ligands for human nuclear retinoic receptors. Skin Pharmacol. 1992; 5: 57-65.
11. Chen J-Y, Clifford J, Zusi C et al. Two distinct actions of retinoid-receptor ligands. Nature 1996; 382: 819-822.
12. Zhang J, Hu X, Lazar MA. A novel role for helix 12 of retinoid X receptor in regulating expression. Mol. Cell. Biol. 1999; 19: 6448-6457.
13. Chen J-Y, Penco S, Ostrowski J et al. RAR-specific agonist/ antagonists which dissociate transactivation and API transrepression inhibit anchorage-independent cell proliferation. EMBO J. 1995; 14: 1187-1197.